Adage Capital Partners’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$44.2M Sell
256,009
-55,648
-18% -$10.3M 0.07% 280
2025
Q4
$62.2M Buy
311,657
+177,122
+132% +$32.1M 0.09% 207
2025
Q3
$21M Buy
134,535
+89,535
+199% +$14.2M 0.03% 454
2025
Q2
$6.83M Buy
+45,000
New +$6M 0.01% 675
2024
Q3
Sell
-42,269
Closed -$8.73M 887
2024
Q2
$8.73M Sell
42,269
-44,914
-52% -$10.2M 0.02% 631
2024
Q1
$23.6M Sell
87,183
-66,872
-43% -$16M 0.04% 404
2023
Q4
$36.4M Buy
154,055
+44,342
+40% +$8.72M 0.08% 271
2023
Q3
$21.5M Buy
109,713
+98,565
+884% +$20.2M 0.05% 378
2023
Q2
$2.34M Buy
11,148
+3,343
+43% +$665K 0.01% 733
2023
Q1
$1.58M Sell
7,805
-43,995
-85% -$9.97M ﹤0.01% 780
2022
Q4
$11.3M Buy
+51,800
New +$11.3M 0.03% 607
2022
Q3
Sell
-52,900
Closed -$11.3M 1060
2022
Q2
$11.3M Buy
52,900
+40,200
+317% +$9.82M 0.03% 640
2022
Q1
$3.61M Sell
12,700
-41,100
-76% -$12.7M 0.01% 858
2021
Q4
$20.3M Sell
53,800
-800
-1% -$311K 0.04% 456
2021
Q3
$22.5M Sell
54,600
-800
-1% -$332K 0.04% 408
2021
Q2
$20.5M Buy
+55,400
New +$18.5M 0.04% 452
2018
Q1
Sell
-150,000
Closed -$16.4M 727
2017
Q4
$16.4M Buy
150,000
+50,000
+50% +$5.44M 0.04% 465
2017
Q3
$10.8M Buy
+100,000
New +$10.3M 0.03% 546
2016
Q1
Sell
-39,500
Closed -$3.17M 692
2015
Q4
$3.17M Buy
+39,500
New +$2.85M 0.01% 632
2015
Q3
Sell
-200,000
Closed -$14.1M 719
2015
Q2
$14.1M Buy
+200,000
New +$14.8M 0.04% 488
2014
Q2
Sell
-614,268
Closed -$37.1M 700
2014
Q1
$37.1M Buy
614,268
+110,000
+22% +$6.41M 0.1% 248
2013
Q4
$26.7M Buy
504,268
+50,000
+11% +$2.51M 0.07% 331
2013
Q3
$21M Sell
454,268
-50,000
-10% -$2.29M 0.06% 364
2013
Q2
$20.7M Buy
+504,268
New +$21.6M 0.06% 350

Other funds holding CRL